Clinical and functional assessment after anticoagulant therapy of acute deep vein thrombosis involving the lower limb

Yonsei Medical Journal

Volumn 44, Issue 4, 2003, Pages 686-693

  Huh, Se Ho ^a   Kim, Dong Ik ^b   Kim, Eun Sook ^b   Lee, Byung Boong ^b   Moon, Ji Young ^b   Joh, Jin Hyun ^b  

^a Eulji University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Anticoagulants; Heparin; Venous thrombosis; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLASMINOGEN; PROTEIN C; PROTEIN S; THROMBOPLASTIN; WARFARIN;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULANT THERAPY; ANTITHROMBIN III DEFICIENCY; ARTICLE; BIOASSAY; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; CAVA VEIN; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FAMILIAL DISEASE; FATALITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; ILIAC VEIN; INGUINAL REGION; LEG COMPRESSION; LEG THROMBOSIS; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PROBABILITY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; QUALITY OF LIFE; SKIN PIGMENTATION; THROMBOPHLEBITIS; THROMBUS; VEIN VALVE;

EID: 0041379113     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.4.686     Document Type: Article

References (27)

1. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels evidence for antithrombotic agents. Chest 1995;108:227S-30S.
2. Collins R, Scrimgeour A, Yusuf S, Phil D, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988;318:1162-73.
3. International Multicentre Trial. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1975;2:45-51.
4. Hull RD, Raskob GE, Resenbloom D, Lemaire J, Pineo GF, Baylis B, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95.
5. Hyers TN, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolitic disease. Chest 1995;108: 335S-51S.
6. Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. N Engl J Med 1982;307:1676-81.
7. Semba CP, Dake MD. Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 1996;9:26-33.
8. Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolyti therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Interv Radiol 1991;2:195-7.
9. Molina JE, Hunter DW, Yedlicka JW. Thrombolytic therapy for iliofemoral venous thrombosis. Vasc Surg 1992;26:630-7.
10. Andriopoulos A, Wirsing P, Botticher R. Results of iliofemoral venous thrombectomy after acute thrombosis. Report on 165 cases. J Cardiovasc Surg 1982;23: 1234.
11. Goto H, Wada T, Matsumoto A, Matsumura H, Soma T. Iliofemoral venous thrombectomy. Follow-up studies of 88 patients. J Cardiovasc Surg 1980;21:341-6.
12. Roder OC, Lorentzen JE, Hansen HJ. Venous thrombectomy for iliofemoral thrombosis. Early and longterm results in 46 consecutive cases. Acta Chir Scand 1984;150:31-4.
13. Ageno W, Turpie AG. Low-molecular weight heparin in the treatment of pulmonary embolism. Semin Vasc Surg 2000;13:189-93.
14. The Columbus Investigators: Low-molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-62.
15. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1986;89 Suppl:26S-35S.
16. Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, et al. Heparin for five days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-4.
17. Gallus A, Jackaman J, Tillet J, Mills W. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986;6:1293-6.
18. Kakkar VV, Lawrence D. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis: a prospective study. Am J Surg 1985;150:54-63.
19. Franzeck UK, Schalch I, Jager KA, Schneider E, Grimm J, Bollinger A. Prospective 12 year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low risk patients. Circulation 1996;93: 74-9.
20. Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med 2000;51:169-85.
21. Ey FS. Hypercoagulability in vascular surgery patients. Ann Vasc Surg 1992;6:313-9.
22. Hirsh J, Piovella F, Pini M. Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med 1989;87:34S-8S.
23. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al. The clinical course of deep vein thrombosis. Prospective long term follow up of 528 symptomatic patients. Haematologica 1997;82:423-8.
24. Markel A, Manzo RA, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: Incidence and time of reccurence. J Vasc Surg 1992;15:377-84.
25. Caprini JA, Arcelus JI, Reyna JJ, Motykie GD, Mohktee D, Zebala LP, et al. Deep vein thrombosis outcome and the level of oral anticoagulation therapy. J Vasc Surg 1999;30:805-12.
26. Haenon JH, Janssen MCH, Langen H, Asten WNJC, Wollersheim H, Heystraten FMJ, et al. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis. J Vasc Surg 1998; 27:472-8.
27. Bundens WP. The use of airplethysmography in the evaluation and treatment of patients with venous stasis disease. Dermatol Surg 1995;21:67-9.